News

Session ID: 2025-06-23:7ee609413051468c4e6f9c01 Player Element ID: V381ffa87_b49d_4af6_8cfd_1faae3d23a46_6258069484001 ...
Cimzia and Humira are prescription drugs used for Crohn’s disease, several types of arthritis, and more. Learn the differences between the medications.
Humira works by blocking the TNF-alpha. The drug is injected under the skin. The latest condition that Humira is expected to be approved for is a medical breakthrough, Medich said.
Humira also competes against Johnson & Johnson 's (JNJ -0.25%) TNF inhibitor Remicade, which was approved by the FDA in 1998. Remicade generated U.S. sales of $995 million in the second quarter ...
Fujifilm Kyowa Kirin Biologics will first focus on the development of a biosimilar of Abbott’s fully human anti-TNF-alpha monoclonal antibody Humira (adalimumab), “a drug with high therapeutic effects ...
In VISUAL-II, the median time to treatment failure was 8.3 months for the placebo group vs. >18 months (not estimable) for the Humira group, as over half of these patients did not experience ...
Note, however, that AbbVie's agreement with Amgen doesn't prevent others from trying to dethrone Humira. Case in point: Boehringer Ingelheim won FDA approval for its biosimilar to Humira in August.
Coherus BioSciences Inc. will launch the cheapest-ever Humira copycat, Yusimry, in July, with a list price of $995 for two autoinjectors, the company said Thursday.
Humira, which is the world’s top-selling drug, generated $14 billion in sales for Abbvie in 2015. The revenue last year alone is double what Abbvie’s former owner, Abbott Laboratories , paid ...